Four loops of the catalytic domain of factor VIIa mediate the effect of the first EGF-like domain substitution on factor VIIa catalytic activity

被引:12
作者
Jin, JP
Perera, L
Stafford, D
Pedersen, L
机构
[1] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Ctr Bioinformat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA
[4] NIEHS, Res Triangle Pk, NC 27709 USA
关键词
blood coagulation factor; macromolecular simulation; tissue factor; structure-function study; domain substitution;
D O I
10.1006/jmbi.2001.4556
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
presence of tissue factor is essential for factor VIIa (FVIIa) to reach its full catalytic potential. The previous work in this laboratory demonstrated that substitution of the EGF1 domain of factor VIIa with that of factor IX (FVII((IXegf1))a) results in a substantial decrease in TF-binding affinity and catalytic activity. Supporting simulations of the solution structures of Ca2+-bound factor VIIa and FVII((IXegf1))a with tissue factor are provided. Mutants are generated, based on the simulation model, to study the effect of EGF1 substitution on catalytic activity. The simulations show larger Gla-EGF1 and EGF1-EGF2 inter-domain motions for FVII((IXegf1))a than for factor VIIa. The catalytic domain of the chimeric factor VIIa has been disturbed and several surface loops in the catalytic domain of FVII((IXegf1))a (Loop 170s (170-182), Loop 1 (185-188) and Loop 2 (221A-225)) manifest larger position fluctuations than wild-type. The position of Loop 140s (142-152) of FVII((IXegf1))a, near the N terminus insertion site of the catalytic domain, shifts relative to factor VIIa, resulting in a slight alteration of the active site. The results suggest that these four loops mediate the effect of the EGF1 domain substitution on the SI site and catalytic residues. To test the model, we prepared mutations of these surface loops, including four FVII mutants, D186A, K188A, L144A and R147A, a FVII mutant with multiple mutations (MM3: L144A + R147A + D186A) and a FVII mutant with Loop 170s partially deleted, Loop 170s(del). The catalytic activities towards a small peptidyl substrate decreased 2.4, 4.5 and 9-fold for Loop 170s(del)a (a, activated), L144Aa and D186Aa, respectively, while MM3a lost almost all catalytic activity. The combined results of the simulations and mutants provide insight into the mechanism by which tissue factor enhances factor VIIa catalytic activity. (C) 2001 Academic Press.
引用
收藏
页码:1503 / 1517
页数:15
相关论文
共 43 条
[1]   The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor [J].
Banner, DW ;
DArcy, A ;
Chene, C ;
Winkler, FK ;
Guha, A ;
Konigsberg, WH ;
Nemerson, Y ;
Kirchhofer, D .
NATURE, 1996, 380 (6569) :41-46
[2]   CRYSTAL-STRUCTURE OF BOVINE TRYPSINOGEN AT 1.8 A RESOLUTION .1. DATA-COLLECTION, APPLICATION OF PATTERSON SEARCH TECHNIQUES AND PRELIMINARY STRUCTURAL INTERPRETATION [J].
BODE, W ;
FEHLHAMMER, H ;
HUBER, R .
JOURNAL OF MOLECULAR BIOLOGY, 1976, 106 (02) :325-335
[3]   TRANSITION OF BOVINE TRYPSINOGEN TO A TRYPSIN-LIKE STATE UPON STRONG LIGAND-BINDING - REFINED CRYSTAL-STRUCTURES OF BOVINE TRYPSINOGEN-PANCREATIC TRYPSIN-INHIBITOR COMPLEX AND OF ITS TERNARY COMPLEX WITH ILE-VAL AT 1.9 A RESOLUTION [J].
BODE, W ;
SCHWAGER, P ;
HUBER, R .
JOURNAL OF MOLECULAR BIOLOGY, 1978, 118 (01) :99-112
[4]   THE ROLES OF FACTOR VIIS STRUCTURAL DOMAINS IN TISSUE FACTOR-BINDING [J].
CHANG, JY ;
STAFFORD, DW ;
STRAIGHT, DL .
BIOCHEMISTRY, 1995, 34 (38) :12227-12232
[5]   A 2ND GENERATION FORCE-FIELD FOR THE SIMULATION OF PROTEINS, NUCLEIC-ACIDS, AND ORGANIC-MOLECULES [J].
CORNELL, WD ;
CIEPLAK, P ;
BAYLY, CI ;
GOULD, IR ;
MERZ, KM ;
FERGUSON, DM ;
SPELLMEYER, DC ;
FOX, T ;
CALDWELL, JW ;
KOLLMAN, PA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (19) :5179-5197
[6]   EFFICIENT AMPLIFICATION USING MEGAPRIMER BY ASYMMETRIC POLYMERASE CHAIN-REACTION [J].
DATTA, AK .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4530-4531
[7]   Peptide exosite inhibitors of factor VIIa as anticoagulants [J].
Dennis, MS ;
Eigenbrot, C ;
Skelton, NJ ;
Ultsch, MH ;
Santell, L ;
Dwyer, MA ;
O'Connell, MP ;
Lazarus, RA .
NATURE, 2000, 404 (6777) :465-470
[8]   Active site modification of factor VIIa affects interactions of the protease domain with tissue factor [J].
Dickinson, CD ;
Ruf, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19875-19879
[9]   Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa [J].
Dickinson, CD ;
Kelly, CR ;
Ruf, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14379-14384
[10]   A SMOOTH PARTICLE MESH EWALD METHOD [J].
ESSMANN, U ;
PERERA, L ;
BERKOWITZ, ML ;
DARDEN, T ;
LEE, H ;
PEDERSEN, LG .
JOURNAL OF CHEMICAL PHYSICS, 1995, 103 (19) :8577-8593